Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells
Authors
Keywords
Endothelial cells, Phosphorylation, Melanoma cells, VEGF signaling, Cancer treatment, Cell proliferation, Angiogenesis, MAPK signaling cascades
Journal
PLoS One
Volume 10, Issue 12, Pages e0145291
Publisher
Public Library of Science (PLoS)
Online
2015-12-23
DOI
10.1371/journal.pone.0145291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition
- (2015) Abdurazzag Abusnina et al. THROMBOSIS AND HAEMOSTASIS
- Crosstalk between ERK, AKT, and cell survival
- (2014) Paul Dent CANCER BIOLOGY & THERAPY
- Delphinidin inhibits VEGF induced-mitochondrial biogenesis and Akt activation in endothelial cells
- (2014) Lucie Duluc et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Advances in targeting cyclic nucleotide phosphodiesterases
- (2014) Donald H. Maurice et al. NATURE REVIEWS DRUG DISCOVERY
- Delphinidin Reduces Cell Proliferation and Induces Apoptosis of Non-Small-Cell Lung Cancer Cells by Targeting EGFR/VEGFR2 Signaling Pathways
- (2013) Harish Chandra Pal et al. PLoS One
- Molecular mechanisms of the cardiovascular protective effects of polyphenols
- (2012) Ramaroson Andriantsitohaina et al. BRITISH JOURNAL OF NUTRITION
- The Cyclic AMP Pathway
- (2012) P. Sassone-Corsi Cold Spring Harbor Perspectives in Biology
- Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and Cancer
- (2012) Sara Arranz et al. Nutrients
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
- (2011) Thérèse Keravis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1
- (2011) Abdurazzag Abusnina et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium
- (2010) Matthieu Chalopin et al. PLoS One
- Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors
- (2009) R. Soleti et al. CARCINOGENESIS
- The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue
- (2009) Roberta L. Gonçalves et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca2+responses in endothelial cells
- (2008) M Campos-Toimil et al. BRITISH JOURNAL OF PHARMACOLOGY
- Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling
- (2008) Sylvie Lamy et al. CARCINOGENESIS
- Protein kinase C promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor
- (2007) H. Xu et al. CARDIOVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search